đź©ş A New Way to Detect Diabetes Earlier in Women
For years, women have been told that prediabetes is the first warning sign before diabetes. By the time it appears, some level of metabolic imbalance has already set in.
But what if the body starts showing signs much earlier—before prediabetes even begins?
Recent research suggests exactly that. And it may change how we think about early detection of diabetes in women.
Looking Beyond Traditional Tests
Most diabetes screening today relies on a few familiar markers: fasting blood sugar, HbA1c (which reflects a three-month average), and the standard two-hour glucose tolerance test.
While these tests are useful, they often identify risk after changes have already progressed.
Researchers are now focusing on a newer marker—the 1-hour glucose level during an Oral Glucose Tolerance Test (OGTT). Instead of waiting two hours, this test captures how the body responds to glucose much earlier.
What makes this significant is simple:
the body may struggle to manage sugar within the first hour itself, even when traditional tests still appear normal.
A New Way to Understand Diabetes Risk
To make sense of this earlier signal, researchers proposed a new staging system for blood sugar health.
In simple terms, it divides people into four stages:
- A normal stage where blood sugar is well controlled
- An early warning stage where the 1-hour glucose level is elevated
- A combined stage where both early warning and prediabetes are present
- And finally, diabetes
The intention behind this model is clear—to identify risk earlier and intervene sooner, especially in individuals who might otherwise go unnoticed.
The Unexpected Discovery
When this new system was studied over time in women, an interesting pattern emerged.
There was a group of women who already had prediabetes, but did not show the early warning signal in the 1-hour test.
They did not fit into any of the defined stages.
Researchers referred to this group informally as “Stage X.”
This finding is important because it challenges a key assumption—that early glucose spikes always happen before prediabetes.
Not One, But Multiple Pathways
What this research highlights is that the journey toward diabetes is not the same for everyone.
Some women follow a more visible path, where early glucose changes appear first and gradually progress.
But others may develop prediabetes more quietly, without those early signals.
This means that relying on a single marker—even a promising one like the 1-hour glucose test—may not capture the full picture.
Understanding the Risk
Over several years of follow-up, the differences between these groups became clearer.
Women who showed early glucose abnormalities tended to progress faster toward more serious dysglycaemia.
Those in the “Stage X” group—without early signals but already in prediabetes—had a moderate level of risk, higher than normal but lower than those with early abnormalities.
In simple terms, even when early warning signs are absent, the risk does not disappear.
Why This Matters for Women in India
This insight becomes even more relevant in the Indian context.
Women here often face layered metabolic challenges—hormonal fluctuations, pregnancy-related glucose changes, higher insulin resistance, and increasingly sedentary lifestyles.
Conditions like PCOS and post-pregnancy metabolic shifts can further complicate early detection.
In such a setting, depending on a single test or threshold may lead to missed opportunities for early intervention.
A More Thoughtful Approach to Screening
The takeaway is not to replace one test with another, but to think more holistically.
A combination of markers—HbA1c, fasting glucose, and OGTT (including the 1-hour value where available)—offers a more complete understanding of metabolic health.
Equally important are lifestyle indicators such as body composition, sleep quality, and daily activity patterns.
The Diafemme Perspective
At Diafemme, we see women’s metabolic health as something deeply individual—not linear, not predictable, and certainly not one-size-fits-all.
This research reinforces a simple but powerful idea:
early detection is not about a single number, but about patterns.
Understanding those patterns allows for more meaningful prevention, rather than late-stage correction.
Closing Thought
Not all women will show early warning signs before prediabetes develops.
And that is precisely why awareness, regular monitoring, and a multi-layered approach to health matter so much.
Because sometimes, what is not visible in one test may still be unfolding quietly within the body.
đź“š Research Reference
Retnakaran R. et al. (2026). Evaluation of new staging schema for the early diagnosis of dysglycaemia.
Published in The Lancet Diabetes & Endocrinology, March 2026.
This article is an independently written interpretation intended for public health awareness and does not reproduce the original publication.
⚠️ Medical Disclaimer
This content is for informational purposes only and is designed specifically for women’s metabolic health awareness. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for medical concerns.
Â
